Preparing Your Laboratory for the CLIA 2024 Proficiency Testing Changes

Adapting to a New Era of Regulations

Revisions to the Clinical Laboratory Improvement Amendments (CLIA) proficiency testing regulations that went into effect on July 11, 2024, are driving change in today’s labs. The updates include 29 newly regulated analytes and tighter proficiency testing acceptable limits for many currently regulated analytes—along with changes to grading and reporting.

In this webinar, we’ll examine these shifts more closely and determine actionable steps laboratorians can take to comply. We'll also discuss the essentials of proficiency testing and how to avoid noncompliance during CLIA inspections. Plus, we will address your specific needs with a Q&A session following the presentation.

Learning Objectives

This webinar will help you:

• Summarize the historical aspects and other provisions of the CLIA Proficiency Testing Final Rule
• Describe the finalized CLIA requirements pertaining to clinical chemistry and immunoassays, including acceptable limits and total allowable error
• Discuss applicable steps laboratorians can take to adhere to CLIA regulatory changes
• Apply essential best practices to avoid noncompliance in proficiency testing and CLIA inspections

Watch On Demand   Download Slides (PDF, 3.3MB)

Fisher Healthcare is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.™ Program. One P.A.C.E.™ credit-hour will be provided for this complimentary basic level program.

Bremansu Osa-Andrews, PhD, DABCC, NRCC, Clinical Assistant Professor of Pathology, Immunology, and Laboratory Medicine; Medical Director of Core Lab Chemistry, Urinalysis, and Immunology; and Medical Director of the Endocrinology Lab at the University of Florida

Dr. Bremansu Osa-Andrews is a board-certified clinical chemist-diplomate of the American Board of Clinical Chemistry (ABCC) and the National Registry of Certified Chemists (NRCC). As an experienced College of American Pathologists (CAP) inspector, he has a profound understanding of CAP/CLIA standards and requirements for clinical laboratories, along with a background in quality assurance, quality control, and regulatory compliance. As a clinical consultant, Osa-Andrews engages with physicians and providers to help guide the diagnosis, prevention, and treatment of diseases through the accurate interpretation of lab test results and amelioration of testing interferences. His research efforts have culminated in several scholarly awards, award-winning abstracts, and oral and poster presentations at Association for Diagnostics & Laboratory Medicine (ADLM) and other professional meetings.